Innoviva (INVA) Non Operating Investment Income (2020 - 2023)

Innoviva (INVA) posted Non Operating Investment Income of $22.7 million for Q3 2023, up 355.52% on a QoQ basis from -$8.9 million in Q3 2022, and up 355.52% year-over-year from $5.0 million in Q3 2022.

Innoviva (INVA) Non Operating Investment Income (2020 - 2023) Analysis & Trends

Innoviva's Non Operating Investment Income history runs 4 years deep, the most recent figure standing at $22.7 million for Q3 2023.

  • Quarterly Non Operating Investment Income rose 355.52% year-over-year to $22.7 million in Q3 2023, while the trailing twelve-month figure through Sep 2023 was -$54.2 million (down 194.95% YoY) and the FY2024 annual result came in at -$5.3 million, down 120.83% from the prior year.
  • Non Operating Investment Income was $22.7 million for Q3 2023 at Innoviva, up from -$8.9 million in the prior quarter.
  • Across five years, Non Operating Investment Income topped out at $134.0 million in Q3 2021 and bottomed at -$58.6 million in Q2 2022.
  • A 4-year average of $16.5 million and a median of $21.9 million in 2020 frame the typical range for Non Operating Investment Income.
  • Annual changes were most pronounced in 2021 — Non Operating Investment Income surged 556.19% — and 2022, when it slumped 229.32%.
  • Innoviva's Non Operating Investment Income stood at -$38.1 million in 2020, then soared by 451.65% to $134.0 million in 2021, then tumbled by 106.63% to -$8.9 million in 2022, then soared by 355.52% to $22.7 million in 2023.
  • Business Quant data shows INVA's Non Operating Investment Income at $22.7 million in Q3 2023, -$8.9 million in Q3 2022, and -$58.6 million in Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Innoviva 1.58 Bn 979.49 Mn 75.83 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2023 22.70 Mn
Sep 30, 2023 22.70 Mn
Sep 30, 2022 -8.88 Mn
Sep 30, 2022 -8.88 Mn
Jun 30, 2022 -58.60 Mn
Jun 30, 2022 -58.60 Mn
Mar 31, 2022 -9.41 Mn
Mar 31, 2022 -9.41 Mn
Sep 30, 2021 133.97 Mn
Sep 30, 2021 133.97 Mn
Jun 30, 2021 45.32 Mn
Jun 30, 2021 45.32 Mn
Mar 31, 2021 55.05 Mn
Mar 31, 2021 55.05 Mn
Dec 31, 2020 -38.10 Mn
Dec 31, 2020 -38.10 Mn
Sep 30, 2020 -29.37 Mn
Sep 30, 2020 -29.37 Mn
Jun 30, 2020 46.70 Mn
Jun 30, 2020 46.70 Mn